Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ray

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Antiviral Therapy|June 9, 2006
In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabineKatyna Borroto-Esoda, Jennifer E Vela, Florence Myrick, et al.
Molecular Pharmaceutics|June 29, 2012
Mechanism for effective lymphoid cell and tissue loading following oral administration of nucleotide prodrug GS-7340Darius Babusis, Truc K Phan, William A Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219Cheng-Yu Tsai, Adrian S Ray, Daniel B Tumas, et al.
Antiviral Research|January 30, 2017
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposuresKirsten M Stray, Yeojin Park, Darius Babusis, et al.
Antiviral Research|October 31, 2002
Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptaseAdrian S Ray, Eisuke Murakami, Celeste N Peterson, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2015
Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapyEisuke Murakami, Ting Wang, Yeojin Park, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2008
Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulationTomas Cihlar, Genevieve Laflamme, Robyn Fisher, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitroEve-Irene Lepist, Truc K Phan, Anupma Roy, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virusWilliam E Delaney, Adrian S Ray, Huiling Yang, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
2('),3(')-didehydro-2('),3(')-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditionsJunxing Shi, Adrian S Ray, Judy S Mathew, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Antiviral Therapy|June 9, 2006
In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabineKatyna Borroto-Esoda, Jennifer E Vela, Florence Myrick, et al.
Molecular Pharmaceutics|June 29, 2012
Mechanism for effective lymphoid cell and tissue loading following oral administration of nucleotide prodrug GS-7340Darius Babusis, Truc K Phan, William A Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219Cheng-Yu Tsai, Adrian S Ray, Daniel B Tumas, et al.
Antiviral Research|January 30, 2017
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposuresKirsten M Stray, Yeojin Park, Darius Babusis, et al.
Antiviral Research|October 31, 2002
Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptaseAdrian S Ray, Eisuke Murakami, Celeste N Peterson, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2015
Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapyEisuke Murakami, Ting Wang, Yeojin Park, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2008
Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulationTomas Cihlar, Genevieve Laflamme, Robyn Fisher, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2012
Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitroEve-Irene Lepist, Truc K Phan, Anupma Roy, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virusWilliam E Delaney, Adrian S Ray, Huiling Yang, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
2('),3(')-didehydro-2('),3(')-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditionsJunxing Shi, Adrian S Ray, Judy S Mathew, et al.
Pageof 11